Versor Investments’s RayzeBio, Inc. Common Stock RYZB Stock Holding History

Versor Investments’s Portfolio RYZB Stock Details RYZB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-80,771	Closed	-$5.02M	–	934
2023 Q4	$5.02M	Buy	+80,771	New	+$2.01M	1.02%	6

Versor Investments's RYZB Position: Q1 2024 in Review

Versor Investments sold out of RayzeBio, Inc. Common Stock (RYZB) in Q1 2024, closing a stake of 80,771 shares — an estimated $5.02M sold.

Versor Investments first reported a position in RYZB in Q4 2023 and held it in 1 quarter. The position peaked at $5.02M in Q4 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.

Versor Investments reported no remaining RayzeBio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Versor Investments sold 80,771 RayzeBio, Inc. Common Stock shares in Q1 2024, an estimated $5.02M.
Versor Investments first reported a position in RayzeBio, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
Versor Investments's RayzeBio, Inc. Common Stock position peaked at $5.02M in Q4 2023.
0 funds tracked by Wall St. Rank held RayzeBio, Inc. Common Stock as of Q1 2024.

Based on Versor Investments's 13F filing for Q1 2024, filed 13 May 2024.